Colonial Trust’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$118K Sell
305
-515
-63% -$191K 0.01% 367
2026
Q1
$240K Sell
820
-124
-13% -$40.8K 0.03% 260
2025
Q4
$331K Sell
944
-312
-25% -$105K 0.04% 221
2025
Q3
$406K Buy
1,256
+27
+2% +$8.4K 0.05% 215
2025
Q2
$478K Sell
1,229
-148
-11% -$59.5K 0.07% 181
2025
Q1
$599K Buy
1,377
+348
+34% +$140K 0.09% 153
2024
Q4
$380K Sell
1,029
-257
-20% -$108K 0.06% 206
2024
Q3
$669K Buy
1,286
+40
+3% +$21.4K 0.1% 153
2024
Q2
$675K Buy
1,246
+104
+9% +$55K 0.12% 134
2024
Q1
$592K Sell
1,142
-5
-0.4% -$2.49K 0.11% 135
2023
Q4
$541K Buy
1,147
+172
+18% +$79.5K 0.11% 138
2023
Q3
$425K Buy
975
+50
+5% +$22.7K 0.1% 148
2023
Q2
$411K Buy
925
+5
+0.5% +$2.31K 0.1% 151
2023
Q1
$423K Buy
920
+456
+98% +$217K 0.11% 151
2022
Q4
$238K Buy
464
+89
+24% +$45.2K 0.07% 188
2022
Q3
$170K Buy
+375
New +$179K 0.05% 209

Other funds holding ELV

Colonial Trust's ELV Position: Q2 2026 in Review

Colonial Trust reduced its Elevance Health (ELV) stake by 63% in Q2 2026, selling an estimated $191K and leaving 305 shares worth $118K. The position accounts for 0.01% of the portfolio, ranked #367.

Colonial Trust first reported a position in ELV in Q3 2022 and has held it in 16 quarters since. The position peaked at $675K in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Colonial Trust held 305 shares of Elevance Health worth $118K as of Q2 2026.
  • Colonial Trust sold 515 Elevance Health shares in Q2 2026, an estimated $191K.
  • Elevance Health made up 0.01% of Colonial Trust's portfolio in Q2 2026, its #367 holding.
  • Colonial Trust first reported a position in Elevance Health in Q3 2022 and has held it in 16 quarters since.
  • Colonial Trust's Elevance Health position peaked at $675K in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.